Big Board

Keyword
Content Ideas
Result Content Idea Research
Result Content Idea Research
1 Researchers gear up for preclinical testing of coronavirus vaccine
2 Coronavirus Vaccine Being Worked On In University Of Miami Lab
3 University of Miami working to develop vaccine
4 Heat Biologic's COVID-19 Vaccine Demonstrates Robust T Cell Driven Immune Response to SARS-CoV-2 in Preclinical Studies | Vaccines | News Channels
5 Heat Biologics reveals its preclinical coronavirus vaccine results
6 Heat Biologics COVID-19 Vaccine Demonstrates Immunogenicity Proof-of-Concept in Pre-Clinical Studies | Vaccines | News Channels
7 Behind the Scenes of the Pandemic
8 Coronavirus Vaccines May Not Work for the Elderly--and This Lab Aims to Change That
9 Heat Biologics and University of Miami
10 UHealth, Miller School fight COVID-19 on the frontlines and in the labs
11 South Florida talent pitches in on worldwide search for coronavirus treatments
12 Morrisville drugmaker says Covid vaccine candidate produces desired effect
13 A pandemic strikes, and an academic community responds
14 Heat Biologics: Meet the team behind a robust COVID-19 vaccine
15 Heat Biologics (HTBX) Reports Publication of Preclinical COVID-19 Vaccine Results
16 Heat Biologics doses first patient in its Phase 1 clinical trial evaluating anti-cancer drug PTX-35
17 Heat Biologics SARS-CoV-2 vaccine generates potent T cell response in pre-clinical trial
18 Heat Biologics Announces Research Collaboration with University of Miami to Develop Vaccine Designed to Protect Against COVID-19 Coronavirus | Vaccines | News Channels
19 During a virtual talk, President Frenk addresses facing COVID-19 with 'adaptability'
20 Top Coronavirus Penny Stocks To Watch Right Now
21 Heat Biologics forms partnership with Waisman Biomanufacturing to manufacture coronavirus vaccine
22 Heat Biologics reveals positive patient survival data from its Phase 2 lung cancer trial
23 Vaccines 101: What to Know While Waiting for the COVID-19 Vaccine
24 Stock Alert: Heat Biologics Down 9%
25 Heat Biologics expands its Phase 2 trial in combination with Merck"s Keytruda to treat non-small cell lung cancer
26 Heat Biologics Reports Fiscal Year 2016 Financial Results